Robinswood Financial’s Iterum Therapeutics ITRM Stock Holding History

Robinswood Financial’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-66	Closed	-$1	–	441
2026 Q1	$1	Hold	66	–	–	﹤0.01%	429
2025 Q4	$22	Buy	+66	New	+$36	﹤0.01%	402

Other funds holding ITRM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Robinswood Financial's ITRM Position: Q2 2026 in Review

Robinswood Financial sold out of Iterum Therapeutics (ITRM) in Q2 2026, closing a stake of 66 shares — an estimated $1 sold.

Robinswood Financial first reported a position in ITRM in Q4 2025 and held it in 2 quarters. The position peaked at $22 in Q4 2025. 2 funds tracked by Wall St. Rank hold ITRM as of Q2 2026.

Robinswood Financial reported no remaining Iterum Therapeutics position as of Q2 2026 after selling out during the quarter.
Robinswood Financial sold 66 Iterum Therapeutics shares in Q2 2026, an estimated $1.
Robinswood Financial first reported a position in Iterum Therapeutics in Q4 2025 and held it in 2 quarters.
Robinswood Financial's Iterum Therapeutics position peaked at $22 in Q4 2025.
2 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.